Document is current
Any future updates will be listed below
-
Authors
Falzoni, Simonetta https://orcid.org/0000-0002-6594-0357
Giuliani, Anna Lisa https://orcid.org/0000-0003-4988-9181
Adinolfi, Elena https://orcid.org/0000-0001-8129-9929
Coutinho-Silva, Robson https://orcid.org/0000-0002-7318-0204
Illes, Peter https://orcid.org/0000-0003-0484-9389
Robson, Simon C. https://orcid.org/0000-0001-6374-0194
Tang, Yong https://orcid.org/0000-0002-2543-066X
Ulrich, Henning https://orcid.org/0000-0002-2114-3815
Kennedy, Charles https://orcid.org/0000-0001-9661-5437
- License Information
-
More Information
Article History
Received: 17 January 2026
Accepted: 27 January 2026
First Online: 12 February 2026
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: CK is Editor-in-Chief of Purinergic Signalling. SCR is a scientific founder of Purinomia Biotech Inc and has provided consultancy services for eGenesis and Merck Pharma; his interests are reviewed and managed by Beth Israel Deaconess Medical Center in accordance with conflict-of-interest policies at Harvard Medical School.
